Remodeling of the peripheral cardiac conduction system in response to pressure overload

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 8, 2012, Pages

  Harris, Brett S ^a   Baicu, Catalin F ^a   Haghshenas, Nicole ^a   Kasiganesan, Harinath ^a   Scholz, Dimitri ^b   Rackley, Mary S ^a   Miquerol, Lucile ^c   Gros, Daniel ^c   Mukherjee, Rupak ^a   O'Brien, Terrence X ^a,d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c AIX MARSEILLE UNIVERSITY   (France)

^d RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Cardiac activation; Cardiac hypertrophy; Connexin40; Connexin43; Connexin45; Hyperpolarization activated cyclic nucleotide gated channel 4; Purkinje fibers

Indexed keywords

CONNEXIN 40; CONNEXIN 43; CONNEXIN 45; GREEN FLUORESCENT PROTEIN; HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL 4; ION CHANNEL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION SYSTEM; HEART VENTRICLE REMODELING; HYPERTROPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURKINJE FIBER; SYSTOLIC BLOOD PRESSURE;

ACTION POTENTIALS; ANIMALS; BLOTTING, WESTERN; CARDIOMEGALY; CELL COUNT; CELL SIZE; CONNEXINS; CONSTRICTION; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEART CONDUCTION SYSTEM; HEMODYNAMICS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MYOCYTES, CARDIAC; PRESSURE; PURKINJE FIBERS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; VENTRICULAR REMODELING;

EID: 84859748889     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00621.2011     Document Type: Article

References (42)

1. Alcolea S, Theveniau-Ruissy M, Jarry-Guichard T, Marics I, Tzouanacou E, Chauvin JP, Brian JP, Moorman AFM, Lamers WF, Gros DB. Downregulation of connexin 45 gene products during mouse heart development. Circ Res 84: 1365-1379, 1999.
2. Barbuti A, Baruscotti M, DiFrancesco D. The pacemaker current from basics to the clinics. J Cardiovasc Electrophysiol 18: 342-347, 2007.
3. Bastide B, Neyses L, Ganten D, Paul M, Willecke K, Traub O. Gap junction protein connexin 40 is preferentially expressed in vascular endothelium and conductive bundles of rat myocardium and is increased under hypertensive conditions. Circ Res 73: 1138-1149, 1993.
4. Bevilacqua LM, Simon AM, Maguire CT, Gehrmann J, Wakimoto H, Paul DL, Berul CI. A targeted disruption in connexin 40 leads to distinct atrioventricular conduction defects. J Interv Card Electrophysiol 4: 459-467, 2000.
5. Bolte S, Cordelieres FP. A guided tour into colocalization analysis in light microscopy. J Micro 244: 213-232, 2006.
6. Borlak J, Thum T. Hallmarks of ion channel gene expression in endstage heart failure. FASEB J 17: 1592-1608, 2003.
7. Bupha-Intr T, Haizlip KM, Janssen PM. Temporal changes in expression of connexin43 after load-induced hypertrophy in vitro. Am J Physiol Heart Circ Physiol 296: H806-H814, 2009.
8. Coppen SR, Dupont E, Rothery S, Severs NJ. Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. Circ Res 82: 232-243, 1998.
9. Coppen SR, Severs NJ, Gourdie RG. Connexin45 (α6) expression delineates an extended conduction system in the embryonic and mature rodent heart. Dev Genet 24: 82-90, 1999.
10. Fernandez-Velasco M, Goren N, Benito G, Blanco-Rivero J, Bosca L, Delgado C. Reginal distribution of hyperpolarization-activated current (If) and hyperpolarization-activated cyclic nucleotide-gated channel mRNA expression in ventricular cells from control and hypertrophied rat hearts. J Physiol 553: 395-405, 2003.
11. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, Veinot JP, Tang ASL, Stewart AFR, Tesson F, Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara L, Bai D. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. New Eng J Med 354: 2677-2688, 2006.
12. Gourdie RG, Severs NJ, Green CR, Rothery S, Germroth P, Thompson RP. The spatial distribution and relative abundance of gap-junctional connexin40 and connexin43 correlate to functional properties of the cardiac atrioventricular conduction system. J Cell Sci 105: 985-991, 1993.
13. Gros D, Jarry-Guichard T, Ten Veide I, de Maziere A, Van Kempen MJ, Davoust J, Briand JP, Moorman AF, Jongsma HJ. Restricted distribution of connexin 40, a gap junctional protein, in mammalian heart. Circ Res 74: 839-851, 1994.
14. Han W, Bao W, Wang Z, Nattel S. Comparision of ion-channel subunit expression in canine cardiac Purkinje fibers and ventricular muscle. Circ Res 91: 790-797, 2002.
15. Harris BS, Spruill L, Edmonson AM, Rackley MS, Benson DW, O'Brien TX, Gourdie RG. Differentiation of cardiac Purkinje fibers requires precise spatiotemporal regulation of Nkx2-5 expression. Dev Dyn 235: 38-49, 2006.
16. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL, Sahn DJ, Schiller NB, Tajik A, Teichholz LE, Weyman AE. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 62: 212-217, 1980.
17. Ishibashi Y, Takahashi M, Isomatsu Y, Qiao F, Iijima Y, Shiraishi H, Simsic JM, Baicu CF, Robbins J, Zile MR, Cooper G. Role of microtubules versus myosin heavy chain isoforms in contractile dysfunction of hypertrophied murine cardiocytes. Am J Physiol Heart Circ Physiol 285: H1270-H1285, 2003.
18. Jansen JA, van Veen TA, de Bakker JM, van Rijen HV. Cardiac connexins and impulse propagation. J Mol Cell Cardiol 48: 76-82, 2010.
19. Johnson CM, Kanter EM, Green KG, Laing JG, Betsuyaku T, Beyer EC, Steinberg TH, Saffitz JE, Yamada KA. Redistribution of connexin45 in gap junctions of connexin43-deficient hearts. Card Res 53: 921-935, 2002.
20. Kaba RA, Coppen SR, Dupont E, Skepper JN, Elneil S, Haw MP, Pepper JR, Yacoub MH, Rothery S, Severs NJ. Comparison of connexin 43, 40 and 45 expression patterns in the developing human and mouse hearts. Cell Commun Adhes 8: 339-343, 2001.
21. Kohno M, Horio T, Yokokawa K, Murakawa K, Yasunari K, Akioka K, Tahara A, Toda I, Takeuchi K, Kurihara N. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am J Med 92: 29-34, 1992.
22. Lang D, Sulkin M, Lou Q, Efimov IR. Optical mapping of action potentials and calcium transients in the mouse heart. J Vis Exp 13: 3275, 2011.
23. Lee RT, Bloch KD, Pfeffer JM, Pfeffer MA, Neer EJ, Seidman CE. Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy. J Clin Invest 81: 431-434, 1988.
24. Mahdavi V, Lompre AM, Chambers AP, Nadal-Ginard B. Cardiac myosin heavy chain isozymic transitions during development and under pathological conditions are regulated at the level of mRNA availability. Eur Heart J, Suppl F: 181-191, 1984.
25. Mercadier JJ. Determinants of cardiac remodeling and progression to heart failure. In: Congestive Heart Failure, edited by Hosenpud JD, Greenberg BH. Philadelphia, PA: Lippincott Williams and Wilkins, 2007.
26. Mercadier JJ, Samuel JL, Michel JB, Zongazo MA, de la Bastie D, Lompre AM, Wisnewsky C, Rappaport L, Lew B, Schwartz K. Atrial natriuretic factor gene expression in rat ventricle during experimental hypertension. Am J Physiol Heart Circ Physiol 257: H979-H987, 1989.
27. Meysen S, Marger L, Hewett KW, Jarry-Guichard T, Agarkova I, Chauvin JP, Perriard JC, Izumo S, Gourdie RG, Mangoni ME, Nargeot J, Gros D, Miquerol L. Nkx2.5 cell-autonomous gene function is required for the postnatal formation of the peripheral ventricular conduction system. Dev Biol 303: 740-753, 2007.
28. Miquerol L, Meysen S, Mangoni M, Bois P, Van Rijen HVM, Abran P, Jongsma H, Nargeot J, Gros D. Architectural and functional asymmetry of the His-Purkinje system of the murine heart. Cardiovasc Res 63: 77-86, 2004.
29. Morley GE, Danik SB, Bernstein S, Sun Y, Rosner G, Gutstein DE, Fishman GI. Reduced intercellular coupling leads to paradoxical propagation across the Purkinje-ventricular junction and aberrant myocardial activation. Proc Natl Acad Sci USA 102: 4126-4129, 2005.
30. Nakagawa O, Ogawa Y, Itoh H, Suga S, Komatsu Y, Kishimoto I, Nishino K, Yoshimasa T, Nakao K. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload. J Clin Invest 96: 1280-1287, 1995.
31. Nattel S, Maguy A, Le Bouter S, Yeh Y. Arrhythomogenicion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87: 425-456, 2007.
32. Qu J, Volpicelli FM, Garcia LI, Sandeep N, Zhang J, Marquez-Rasado L, Iampe PD, Fishman GI. Gap junction remodeling and spironolactone-dependent reverse remodeling in the hypertrophied heart. Circ Res 104: 365-371, 2009.
33. Remme CA, Verkerk AO, Hoogaars WMH, Aanhaanen WTJ, Scicluna BP, Annink C, van den Hoff MJ, Wilde AA, van Veen TA, Veldkamp MW, de Bakker JM, Christoffels VM, Bezzina CR. The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol 104: 511-522, 2009.
34. Scheinman MM. Role of the His-purkinje system in the genesis of cardiac arrhythmia. Heart Rhythm 6: 1050-1058, 2009.
35. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiog 2: 358-367, 1989.
36. Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, Schaper W. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 34: 775-787, 2002.
37. Severs NJ, Coppen SR, Dupont E, Yeh H, Ko Y, Matsushita T. Gap junction alterations in human cardiac disease. Cardiovasc Res 62: 368-377, 2004.
38. Steiber J, Hermann S, Feli S, Loster J, Feil R, Biel M, Hofmann F, Ludwig A. The hyperpolarization-activated channel HCN4 is required for generation of pacemaker action potentials in the embryonic heart. Proc Natl Acad Sci USA 100: 15235-15240, 2003.
39. Stillitano F, Lonardo G, Zicha S, Varro A, Cerbai E, Mugelli A, Nattel S. Molecular basis of funny current (If) in normal and failing human heart. J Mol Cell Cardiol 45: 289-299, 2008.
40. Yamada KA, Rogers JG, Sundset R, Steinberg TH, Saffitz JE. Upregulation of connexin45 in heart failure. J Cardiovasc Electrophysiol 14: 1205-1212, 2003.
41. Zähringer J, Klaubert A, Pritzl N, Stangl E, Kreuzer E. Gene expression in cardiac hypertrophy in rat and human heart muscle. Eur Heart J, Suppl F: 199-210, 1984.
42. Zinchuk V, Zinchuk O, Okada T. Quantitative colocalization analysis of multicolor confocal immunofluorescence microscopy images: pushing pixels to explore biological phenomena. Acta Histochem Cytochem 40: 101-111, 2007.